Jeff Frelick - 11 Sep 2023 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Role: Chief Executive Officer
Signature: /s/ Jeffrey Frelick
Issuer symbol: BBLG
Transactions as of: 11 Sep 2023
Net transactions value: +$6,530
Form type: 4
Filing time: 12 Sep 2023, 12:34:57 UTC
Previous filing: 05 Sep 2023
Next filing: 19 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBLG	Common Stock	Purchase	$6,530	+9,500	+123%	$0.6874	17,204	11 Sep 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6898, inclusive. Mr. Frelick undertakes to provide Bone Biologics Corporation, any security holder of Bone Biologics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6799 to $0.6898, inclusive. Mr. Frelick undertakes to provide Bone Biologics Corporation, any security holder of Bone Biologics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.